Today: 4 March 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Newsmax (NMAX) Stock on December 6, 2025: Price, Q3 Earnings, Forecasts and Risks Explained

Newsmax (NMAX) Stock on December 6, 2025: Price, Q3 Earnings, Forecasts and Risks Explained

Newsmax Inc. (NYSE: NMAX) closed at $8.11 on December 5, 2025, down over 90% from its April highs after a volatile post-IPO run. The company reported Q3 revenue of $45.3 million and a net loss of $4.1 million. Analyst coverage remains sparse, but consensus rates the stock a “Strong Buy” with a $21–23 target. Technical models remain cautious or negative.
Starbucks (SBUX) Stock Outlook December 2025: Strike Fallout, NYC Settlement and Analyst Forecasts

Starbucks (SBUX) Stock Outlook December 2025: Strike Fallout, NYC Settlement and Analyst Forecasts

Starbucks closed at $85.12 on December 5, 2025, down 15% over the past year, with a trailing P/E of about 52x and forward P/E near 36x. The company faces a historic U.S. barista strike at 120 stores, a $38.9 million New York City settlement, and thin margins despite Q4 revenue growth. Wall Street targets average $97–$101, but some models warn of overvaluation. Amundi raised its stake by 12% to over 4 million shares.
6 December 2025
Snowflake (SNOW) Stock on December 6, 2025: Earnings Shock, AI Partnerships and Fresh Price Targets

Snowflake (SNOW) Stock on December 6, 2025: Earnings Shock, AI Partnerships and Fresh Price Targets

Snowflake shares fell 9% this week, closing at $228.79 on Friday after issuing softer Q4 guidance despite strong Q3 results. The company reported Q3 revenue of $1.21 billion, up 29% year-over-year, but forecast slower product revenue growth and lower margins, citing discounts on large deals and increased AI investment.
QuantumScape (QS) Stock: Latest News, Analyst Price Targets and Solid‑State Battery Outlook – December 6, 2025

QuantumScape (QS) Stock: Latest News, Analyst Price Targets and Solid‑State Battery Outlook – December 6, 2025

QuantumScape shares closed at $12.56 on December 5, down 3.2% for the day and well below their June high of $19, but still far above the 52-week low of $3.40. The company’s market cap stands near $7.5 billion, despite reporting nearly zero GAAP revenue. Analysts’ 12-month price targets average $8.81, with some as low as $2.50.
Eli Lilly (LLY) Stock on 6 December 2025: Zepbound Price Cuts, $1 Trillion Milestone and 2026 Forecasts

Eli Lilly (LLY) Stock on 6 December 2025: Zepbound Price Cuts, $1 Trillion Milestone and 2026 Forecasts

Eli Lilly shares traded near $1,010 on December 6, 2025, with a market value just under $1 trillion after a brief pullback from record highs. The company cut list prices on Zepbound vials this week, pressuring margins and sending the stock lower. Zepbound and Mounjaro generated $10.1 billion in Q3 sales, making Lilly’s GLP-1 drugs the world’s top-selling franchise. Most analysts maintain Buy ratings, with 12-month targets around $1,060–$1,090.
Moderna (MRNA) Stock Jumps on Vaccine Safety Study and $1.5B Lifeline: Latest News and Forecasts as of December 6, 2025

Moderna (MRNA) Stock Jumps on Vaccine Safety Study and $1.5B Lifeline: Latest News and Forecasts as of December 6, 2025

Moderna shares closed at $27.70 on December 5, up 8.7% on volume over 16 million. The rally followed a major French study showing no increase in long-term mortality from mRNA COVID vaccines and a new $1.5 billion credit facility. The stock is still down more than 50% over the past year despite recent gains. Year-to-date performance remains negative at –38.7%.
Snap Inc (SNAP) Stock Outlook – December 2025: Russia Ban, AI Deals and AR Bets Put the Spotlight Back on Snapchat

Snap Inc (SNAP) Stock Outlook – December 2025: Russia Ban, AI Deals and AR Bets Put the Spotlight Back on Snapchat

Snap Inc. shares closed at $7.91 on December 5, up 1.9% for the day but still 40% below their 52-week high and 91% under the 2021 peak. Q3 revenue rose 10% to $1.51 billion, with daily active users at 477 million. Russia banned Snapchat, and Australia will require age verification. Analysts rate SNAP a “Hold” with price targets averaging $9.5–$10.5.
McDonald’s (MCD) Stock on December 6, 2025: Latest News, Analyst Forecasts, Dividend Hike and Holiday Catalysts

McDonald’s (MCD) Stock on December 6, 2025: Latest News, Analyst Forecasts, Dividend Hike and Holiday Catalysts

McDonald’s closed at $311.11 on December 5, 2025, near record highs, with a market cap of about $221 billion. Institutional investors, including Epoch Investment Partners, increased stakes as insiders sold roughly 40,000 shares in recent months. The company announced a 5% dividend hike and launched a limited-time Grinch Meal for the holiday season. Year-to-date, the stock is up about 7.3%.
6 December 2025
Bendigo Bank’s $5.2 Billion RACQ Deal Meets AML Turbulence: What It Means for Customers and BEN Shares (Updated 6 December 2025)

Bendigo Bank’s $5.2 Billion RACQ Deal Meets AML Turbulence: What It Means for Customers and BEN Shares (Updated 6 December 2025)

Bendigo and Adelaide Bank has agreed to buy RACQ Bank’s retail loan and deposit book, shifting A$5.2 billion in assets and over 90,000 customers, mostly in Queensland. The deal, funded from cash reserves and set to complete between late 2026 and early 2027, comes as Bendigo faces an anti–money laundering review, a police investigation, and new job cuts.
ASML Holding NV Stock (ASML): December 6, 2025 – Price, Fresh Buying, AI Tailwinds and 2026 Growth Risks

ASML Holding NV Stock (ASML): December 6, 2025 – Price, Fresh Buying, AI Tailwinds and 2026 Growth Risks

ASML shares traded near $1,099 on December 6, 2025, close to a 52-week high, with a market cap of $432 billion. The stock is up 48% over the past year. New 13F filings show increased institutional buying, including a larger stake from 1832 Asset Management and a new position by Clear Street LLC. Q3 net sales reached €7.5 billion, with net income of €2.1 billion.
6 December 2025
CVS Stock Outlook: Fresh Legal Headlines, Analyst Upgrades and 2026 Forecast (December 6, 2025)

CVS Stock Outlook: Fresh Legal Headlines, Analyst Upgrades and 2026 Forecast (December 6, 2025)

CVS Health shares traded near $75.60 on December 6, 2025, after a strong rally and a series of legal settlements, including a $37.8 million insulin pen case and an $18.2 million False Claims Act settlement. A federal judge also ordered CVS Caremark to pay nearly $290 million for Medicare overcharges. Management raised 2025 profit guidance and projected double-digit earnings growth for 2026.
6 December 2025
Marvell Technology (MRVL) Stock Surges on AI Momentum: Latest News, Analyst Forecasts and Outlook as of December 6, 2025

Marvell Technology (MRVL) Stock Surges on AI Momentum: Latest News, Analyst Forecasts and Outlook as of December 6, 2025

Marvell Technology reported record Q3 FY2026 revenue of $2.08 billion, up 37% year over year, and non-GAAP EPS of $0.76, boosted by strong AI data center demand. Shares closed at $98.91 on December 5, near multi-month highs. The company announced a $3.25 billion acquisition of Celestial AI and raised Q4 guidance above Wall Street estimates.
Central Dakota Ag Day 2025 Highlights Cybersecurity as SDSU Holiday Open Launches Indoor Season

Central Dakota Ag Day 2025 Highlights Cybersecurity as SDSU Holiday Open Launches Indoor Season

North Dakota State University Extension will host Central Dakota Ag Day on Dec. 19 in Carrington, focusing on cybersecurity, robotic weed control, and livestock health for producers. The event features a keynote on farm cybersecurity and multiple breakout sessions, with no registration required. Meanwhile, South Dakota’s top track and field programs opened the indoor season with record performances at the SDSU Holiday Open in Brookings.
6 December 2025
AppLovin (APP) Stock Soars on AI Adtech Boom: Latest News, SEC Probe, Price Targets and 2025–2030 Forecast

AppLovin (APP) Stock Soars on AI Adtech Boom: Latest News, SEC Probe, Price Targets and 2025–2030 Forecast

AppLovin shares traded near $691.94 on December 6, 2025, close to a record high and up 80% in a year, with a market cap near $231 billion. Q3 revenue jumped 68% to $1.41 billion and net income hit $836 million. Institutional investment surged after S&P 500 inclusion in September. The company faces SEC scrutiny over data practices, insider selling, and a forward P/E in the mid-40s.
MP Materials (MP) Stock: Insider Selling, Government Deals and Analyst Upgrades – Latest News & Forecasts as of December 6, 2025

MP Materials (MP) Stock: Insider Selling, Government Deals and Analyst Upgrades – Latest News & Forecasts as of December 6, 2025

MP Materials CEO James Litinsky sold 385,000 shares on December 5, raising about $24.2 million at prices between $62.79 and $63.42. The stock closed at $62.17 that day, down sharply from its October peak near $99. MP announced a joint venture with the U.S. Department of War and Saudi Arabian Mining Company to develop rare earths. The company remains unprofitable with negative margins.
6 December 2025
1 620 621 622 623 624 685
Go toTop